Navigation Links
PlatformQ Health Kicks Off New Partnership with Primary Care Network with Online Migraine CME Program at NeuroSeriesLive
Date:1/13/2016

PlatformQ Health the parent company of NeuroSeriesLive and Primary Care Network will provide primary care clinicians, including those who specialize in internal medicine and family medicine, physician assistants, and nurse practitioners with an opportunity to hear migraine experts discuss the latest science around managing patients with acute migraine live via online video at no cost at NeuroSeriesLive. The event will be held on January 15, 2016, at 1:00 PM ET at http://www.NeuroSeriesLive.com. The program will mark the first event accredited and co-marketed as part of a new partnership with Primary Care Network. Primary Care Network is a leader in continuing medical education for primary care clinicians.

PlatformQ Health Executive Vice President David Murphy, “We are excited to collaborate with Primary Care Network to accredited and co-market our virtual events for US primary care clinicians. PlatformQ Health and Primary Care Network have a shared goal to provide health care providers with quality accredited online education that improves their knowledge, access to the latest science, top thought leaders and ultimately improve patient care.”

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network and PlatformQ Health Education, LLC. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.

The program will feature Michael J. Marmura, MD, and Stephen D. Silberstein, MD, both of Jefferson Headache Center. Topics in the hour-long program will include: Rationale, timing and patient suitability for acute migraine treatment; benefits and limitations of various treatment options; use of prophylactic medication, and individualized acute treatment options. This activity is supported by an educational grant from Avanir Pharmaceuticals.

NeuroSeriesLive offers an effective way for clinicians to easily stay current on advances in care without leaving their office. There is no cost to register and watch any educational session at NeuroSeriesLive. Clinicians who attend live may take advantage of interactive capabilities like submitting questions to be addressed live online by presenting faculty and interactive polling.

To learn more and register at no cost for this live interactive video webcast, visit http://www.NeuroSeriesLive.com

About NeuroSeriesLive
NeuroSeriesLive is a leader in online CME programs in Neurology treatment and science produced by PlatformQ Health, Inc. NeuroSeriesLive enables neurologists, internal medicine specialists, family care physicians and other healthcare practitioners interested in understanding and managing patients with neurologic disorders to learn, connect and interact in real time. NeuroSeriesLive offers virtual medical education at no cost and delivers all the benefits of a physical conference, with live presentations, real-time interactive Q&A, and an exhibit floor, all from the convenience of a computer.

To learn more about NeuroSeriesLive, follow us via Twitter at @NeuroSeriesLive.

Read the full story at http://www.prweb.com/releases/2016/01/prweb13162090.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. How Untreated Hyperglycemia Can Lead to Kidney Failure and Disease Discussed in New Video From Health Nutrition News
2. The Global Awards World’s Best Healthcare Advertising Hosts Celebrations in New York City & Sydney, Australia
3. Better tests needed to improve patient care, public health
4. Female Cellulite Solution Review Released by Health News Wires
5. Health Plans 4 Less™ Offers Tips to Individuals and Businesses on How they Will be Affected by Obamacare
6. Allegheny Health Network Partners with Region’s EMS Providers to Advance Treatment of Heart Attack Patients
7. B. Braun Will Sponsor Practice Greenhealth DEHP-Free Award
8. Mississippi Department of Mental Health Selects CoCENTRIX for EHR and to Coordinate Care for Its Citizens Treated in State Behavioral Health and I/DD Programs
9. Rapid Insight and HealthDataViz Partner to Bring Predictive Analytics to Healthcare
10. Some Imaging Tests Not Worth the Costs and Risks, From the November 2013 Harvard Women's Health Watch
11. Fenway Health Releases Transgender Awareness Week 2013 Infographic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... ... “They Sang At Her Funeral”: a tale of murder that will bring ... their closets. “They Sang At Her Funeral” is the creation of published author, Annalise ... five children and twelve grandchildren. Before becoming a writer, Annalise had the opportunity to ...
(Date:9/19/2017)... ... 2017 , ... Only a few physicians were selected to receive the prestigious ... Clevens, MD, FACS . The founder and medical director of Clevens Face and ... at Yale, Harvard and the University of Michigan. He has served patients throughout Central ...
(Date:9/19/2017)... ... , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two important milestones. To ... $835 million in resolved debt for its clients. , Credit card debt, unpaid hospital ... of debt settled by the company. With more than a decade of combined service ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... Texas as a part of its national Swirl: A Wine Tasting Event series ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has ... filter. When we’re born, Nature gives us a full supply of melanin – ... we continuously lose this natural glare-reducing pigment; however, around the age of thirty, we ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017  Medical ... knowledge and skills while treating their patients. ... hands-on experience without involving patients. Simulation provides ... Clinicians can carry out procedures, refine techniques ... risk. Integration of new technology, such as ...
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Sept. 5, 2017  Getinge, a leading global ... vibrant charitable donation program -- "Color for the ... heart defect research by The Children,s Heart Foundation. ... general public are encouraged to download a coloring ... completed artwork to the gallery on the website. ...
Breaking Medicine Technology: